FDA Adverse Event Injury Summary report: N

JUVEDERM ULTRA

MDR report key: 2881552 · Received December 18, 2012

Report

Report Number
3005113652-2012-00130
Event Type
Injury
Date Received
December 18, 2012
Date of Event
November 15, 2012
Report Date
November 23, 2012
Manufacturer
ALLERGAN
Product Code
LMH
PMA / PMN Number
P050047
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

ALLERGAN REPRESENTATIVE REPORTED RECEIVING A REPORT FROM THE PHYSICIAN WHO NOTED THAT AFTER INJECTION WITH THREE (3) SYRINGES OF JUVEDERM ULTRA IN THE "LACRIMAL GROOVES, MALLARS, LIPS AND NASOLABIAL FOLDS", PATIENT EXPERIENCED "INTENSE EDEMA REACTIONS AND HYPEREMIA ON THE LEFT HEMIFACE, BEING MORE INTENSE ON THE DISTAL REGIONS OF THE NASOLABIAL FOLD AND LOWER MALLAR" ONE WEEK LATER. IN ADDITION, PATIENT "LOST A NEVUS THAT SHE HAD NEXT TO APPLICATION." PATIENT WAS TREATED WITH "CEFALEXIN DURING 7 DAYS AND MADE AN APPLICATION OF DIPROSAN INTRAMUSCULARLY." PATIENT IMPROVED PARTIALLY BUT RECEIVED AN ADDITIONAL TREATMENT OF "AN INJECTION OF DIPROSAN AND PRESCRIBED NONSTEROIDAL ANTI-INFLAMMATORY."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 JUVEDERM ULTRA LMH ALLERGAN NA NI

Patients

Seq Age Sex Outcome Treatment
1 NI Required Intervention